Literature DB >> 12552055

Somatic mosaicism and variable penetrance in doublecortin-associated migration disorders.

L Aigner1, G Uyanik, S Couillard-Despres, S Ploetz, G Wolff, D Morris-Rosendahl, P Martin, U Eckel, S Spranger, J Otte, H Woerle, H Holthausen, N Apheshiotis, D Fluegel, J Winkler.   

Abstract

X-linked isolated lissencephaly sequence (XLIS) and subcortical band heterotopia (SBH) are allelic disorders caused by mutations in the doublecortin (DCX) gene. This genetic analysis of seven families revealed four novel mutations in the DCX gene. The authors detected a high rate of somatic mosaicism in male and female patients with variable penetrance of bilateral SBH including nonpenetrance in a heterozygous woman. In addition, the authors implemented prenatal diagnosis in a family with SBH/XLIS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12552055     DOI: 10.1212/01.wnl.0000042091.90361.d2

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  9 in total

Review 1.  Comprehensive genotype-phenotype correlation in lissencephaly.

Authors:  Ai Peng Tan; Wui Khean Chong; Kshitij Mankad
Journal:  Quant Imaging Med Surg       Date:  2018-08

Review 2.  Genetics, molecular biology, and phenotypes of x-linked epilepsy.

Authors:  Hao Deng; Wen Zheng; Zhi Song
Journal:  Mol Neurobiol       Date:  2013-11-22       Impact factor: 5.590

3.  The location of DCX mutations predicts malformation severity in X-linked lissencephaly.

Authors:  Pierre-Louis Leger; Isabelle Souville; Nathalie Boddaert; Caroline Elie; Jean Marc Pinard; Perrine Plouin; Marie Laure Moutard; Vincent des Portes; Hilde Van Esch; Sylvie Joriot; Jean Louis Renard; Jamel Chelly; Fiona Francis; Cherif Beldjord; Nadia Bahi-Buisson
Journal:  Neurogenetics       Date:  2008-08-07       Impact factor: 2.660

4.  Mosaic DCX deletion causes subcortical band heterotopia in males.

Authors:  Chloé Quélin; Yoann Saillour; Isabelle Souville; Karine Poirier; Marie Ange N'guyen-Morel; Laurent Vercueil; Anne Elodie Millisher-Bellaiche; Nathalie Boddaert; Fanny Dubois; Jamel Chelly; Cherif Beldjord; Nadia Bahi-Buisson
Journal:  Neurogenetics       Date:  2012-07-26       Impact factor: 2.660

5.  New insights into genotype-phenotype correlations for the doublecortin-related lissencephaly spectrum.

Authors:  Nadia Bahi-Buisson; Isabelle Souville; Franck J Fourniol; Aurelie Toussaint; Carolyn A Moores; Anne Houdusse; Jean Yves Lemaitre; Karine Poirier; Reham Khalaf-Nazzal; Marie Hully; Pierre Louis Leger; Caroline Elie; Nathalie Boddaert; Cherif Beldjord; Jamel Chelly; Fiona Francis
Journal:  Brain       Date:  2013-01       Impact factor: 13.501

6.  Mitotic impairment by doublecortin is diminished by doublecortin mutations found in patients.

Authors:  Sebastien Couillard-Despres; Goekhan Uyanik; Sonja Ploetz; Claudia Karl; Hartmut Koch; Juergen Winkler; Ludwig Aigner
Journal:  Neurogenetics       Date:  2004-03-25       Impact factor: 2.660

7.  Novel NEXMIF pathogenic variant in a boy with severe autistic features, intellectual disability, and epilepsy, and his mildly affected mother.

Authors:  Nelle Lambert; Corinne Dauve; Emmanuelle Ranza; Periklis Makrythanasis; Federico Santoni; Frédérique Sloan-Béna; Stefania Gimelli; Jean-Louis Blouin; Michel Guipponi; Armand Bottani; Stylianos E Antonarakis; Markus M Kosel; Joel Fluss; Ariane Paoloni-Giacobino
Journal:  J Hum Genet       Date:  2018-05-01       Impact factor: 3.172

Review 8.  Role of cytoskeletal abnormalities in the neuropathology and pathophysiology of type I lissencephaly.

Authors:  Gaëlle Friocourt; Pascale Marcorelles; Pascale Saugier-Veber; Marie-Lise Quille; Stephane Marret; Annie Laquerrière
Journal:  Acta Neuropathol       Date:  2010-11-03       Impact factor: 17.088

9.  A novel missense mutation of doublecortin: mutation analysis of Korean patients with subcortical band heterotopia.

Authors:  Myeong-Kyu Kim; Man-Seok Park; Byeong-Chae Kim; Ki-Hyun Cho; Young-Seon Kim; Jin-Hee Kim; Min-Cheol Lee; Tag Heo; Eun-Young Kim
Journal:  J Korean Med Sci       Date:  2005-08       Impact factor: 2.153

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.